| A roadmap for interpreting 13C metabolite labeling patterns from cells JM Buescher, MR Antoniewicz, LG Boros, SC Burgess, H Brunengraber, ... Current opinion in biotechnology 34, 189-201, 2015 | 603 | 2015 |
| 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth Y Hu, L Qiao, S Wang, S Rong, EJ Meuillet, M Berggren, A Gallegos, ... Journal of medicinal chemistry 43 (16), 3045-3051, 2000 | 245 | 2000 |
| Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor … EJ Meuillet, D Mahadevan, M Berggren, A Coon, G Powis Archives of biochemistry and biophysics 429 (2), 123-133, 2004 | 238 | 2004 |
| Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides EA Miljan, EJ Meuillet, B Mania-Farnell, D George, H Yamamoto, ... Journal of Biological Chemistry 277 (12), 10108-10113, 2002 | 194 | 2002 |
| Deoxycholic acid induces intracellular signaling through membrane perturbations S Jean-Louis, S Akare, MA Ali, EA Mash, E Meuillet, JD Martinez Journal of Biological Chemistry 281 (21), 14948-14960, 2006 | 140 | 2006 |
| NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III1 TS Dexheimer, SS Carey, S Zuohe, VM Gokhale, X Hu, LB Murata, ... Molecular cancer therapeutics 8 (5), 1363-1377, 2009 | 131 | 2009 |
| Identification and development of mPGES-1 inhibitors: where we are at? HH Chang, EJ Meuillet Future medicinal chemistry 3 (15), 1909-1934, 2011 | 120 | 2011 |
| mPGES-1 as a target for cancer suppression: A comprehensive invited review “Phospholipase A2 and lipid mediators” M Nakanishi, V Gokhale, EJ Meuillet, DW Rosenberg Biochimie 92 (6), 660-664, 2010 | 120 | 2010 |
| Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings E Meuillet, S Stratton, D Prasad Cherukuri, AC Goulet, J Kagey, ... Journal of cellular biochemistry 91 (3), 443-458, 2004 | 120 | 2004 |
| Specific Inhibition of the Akt1 Pleckstrin Homology Domain by D-3-Deoxy-Phosphatidyl-myo-Inositol Analogues EJ Meuillet, D Mahadevan, H Vankayalapati, M Berggren, R Williams, ... Molecular cancer therapeutics 2 (4), 389-399, 2003 | 119 | 2003 |
| Gene transfection-mediated overexpression of β1, 4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function A Rebbaa, H Yamamoto, T Saito, E Meuillet, P Kim, DS Kersey, ... Journal of Biological Chemistry 272 (14), 9275-9279, 1997 | 108 | 1997 |
| Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine KM Block, H Wang, LZ Szabó, NW Polaske, LK Henchey, R Dubey, ... Journal of the American Chemical Society 131 (50), 18078-18088, 2009 | 103 | 2009 |
| The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells DP Cherukuri, XBO Chen, AC Goulet, RN Young, Y Han, RL Heimark, ... Experimental cell research 313 (14), 2969-2979, 2007 | 102 | 2007 |
| Submolecular regulation of cell transformation by deuterium depleting water exchange reactions in the tricarboxylic acid substrate cycle LG Boros, DP D’Agostino, HE Katz, JP Roth, EJ Meuillet, G Somlyai Medical hypotheses 87, 69-74, 2016 | 100 | 2016 |
| Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 (‘Iressa’) B Stea, R Falsey, K Kislin, J Patel, H Glanzberg, S Carey, AA Ambrad, ... Cancer letters 202 (1), 43-51, 2003 | 100 | 2003 |
| Discovery of a novel class of AKT pleckstrin homology domain inhibitors D Mahadevan, G Powis, EA Mash, B George, VM Gokhale, S Zhang, ... Molecular cancer therapeutics 7 (9), 2621-2632, 2008 | 94 | 2008 |
| Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor EJ Meuillet, S Zuohe, R Lemos, N Ihle, J Kingston, R Watkins, SA Moses, ... Molecular cancer therapeutics 9 (3), 706-717, 2010 | 84 | 2010 |
| Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431 EJ Meuillet, B Mania-Farnell, D George, JI Inokuchi, EG Bremer Experimental Cell Research 256 (1), 74-82, 2000 | 80 | 2000 |
| Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431 EJ Meuillet, R Kroes, H Yamamoto, TG Warner, J Ferrari, B Mania-Farnell, ... Cancer research 59 (1), 234-240, 1999 | 80 | 1999 |
| Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase–dependent clonogenic response in acute myeloid leukemia cells AF List, B Glinsmann-Gibson, C Stadheim, EJ Meuillet, W Bellamy, ... Experimental Hematology 32 (6), 526-535, 2004 | 76 | 2004 |
